Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01093924 · ClinicalTrials.gov registry record · NA
Partnerships to Overcome Obesity Disparities in Hawaii: 18-month CBPR Study
A NA study, sponsored by University of Hawaii.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT01093924: Completed NA study, sponsored by University of Hawaii.
NCT01093924 is a NA study that has completed, run by University of Hawaii. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01093924, a NA study, has completed, sponsored by University of Hawaii.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
This is a 5-year community-based participatory research intervention study with the goals of 1) conducting a more definitive study of weight loss maintenance in Native Hawaiians and Pacific Peoples and 2) identifying the aspects of the community-academic partnership that fosters a co-learning and co-equal environment.
Primary Outcome
Amount of Weight loss in kilograms from baseline to 18 month follow-up
Interventions
- BEHAVIORAL PILI 'Ohana 18-month weight loss maintenance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2009-10 |
| Est. Completion | 2013-02 |
| Phase | NA |
What the finished NCT01093924 record still lists
NCT01093924 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which PILI 'Ohana 18-month weight loss maintenance is the first listed.
NCT01093924 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01093924 about?
NCT01093924 is a clinical study titled "Partnerships to Overcome Obesity Disparities in Hawaii: 18-month CBPR Study". This is a 5-year community-based participatory research intervention study with the goals of 1) conducting a more definitive study of weight loss maintenance in Native Hawaiians and Pacific Peoples and 2) identifying the aspects of the community-academic partnership that fosters a co-learning and co...
What is the current status of trial NCT01093924?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2009-10. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01093924?
The interventions under investigation include: PILI 'Ohana 18-month weight loss maintenance (BEHAVIORAL).
Who is sponsoring clinical trial NCT01093924?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01093924's enrollment target sits among peer trials
240 440th of 2000 higher than 1,542 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia